News

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancerSALT LAKE CITY,…

8 months ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

CARMEL, Ind., Aug. 22, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology…

8 months ago

Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape

Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern TimeAUSTIN, Texas, Aug. 22, 2023 (GLOBE NEWSWIRE) --…

8 months ago

Healthcare Financial Management Association offers finance education in the Middle East

CHICAGO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) is offering a new international educational opportunity…

8 months ago

AMN Passport Surpasses 200,000 Downloads: The Most Downloaded Mobile App in Healthcare Staffing Industry

DALLAS, Aug. 22, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare’s (NYSE: AMN) mobile app, AMN Passport has surpassed 200,000 registered, ready-to-work…

8 months ago

Ashvattha Therapeutics Presents Promising Preclinical Data on New Dendranib Nanomedicine Candidate ASH41020 at the 16th International Society of Neuroimmunology Congress (ISNI)

Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward the anti-inflammatory M2 phenotypeASH41020 treatment…

8 months ago

Shockwave Medical to Participate in Upcoming Investor Conferences

SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and…

8 months ago

SELLAS Life Sciences Independent Data Monitoring Committee Recommends Galinpepimut-S REGAL Trial to Continue Without any Modifications

REGAL Interim Analysis Expected by Late 2023/Early 2024 Enrollment Expected to be Completed in Q4 2023 NEW YORK, Aug. 22,…

8 months ago

Jupiter Wellness Announces Darren Heitner, Esq. Sports Attorney and Influencer Signs on as Brand Ambassador for Safety Shot

Jupiter Wellness, Inc Darren HeitnerHeitner has been referred to as one of the foremost experts on name, image, and likeness…

8 months ago

Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.

Combined company, focused on sustainable, equitable food portfolio, expected to more readily penetrate new markets and accelerate transition to animal-free…

8 months ago